http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114796480-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2711ddefa9b50969da314d7bd318cdba
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_72206ca96c18ac1fe3f5b21bb02a5bb1
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55505
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55583
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39
filingDate 2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14171f073aaca3e4189580fc01578e18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c0cd2b5bdee155416a34c42db61d11f7
publicationDate 2022-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114796480-A
titleOfInvention A kind of preparation method of composite nanoparticle aluminum adjuvant
abstract A preparation method of a composite nanoparticle aluminum adjuvant relates to the technical field of vaccine adjuvants, in particular to a preparation method of a nanocomposite vaccine adjuvant. The purpose is to solve the problem that the existing aluminum salt adjuvant lacks the ability to induce Th1-type immune response and cannot induce mucosal immune response. Methods: 1. Configure soluble aluminum salt solution. 2. Preparation of N-2-hydroxypropyltrimethylammonium chloride chitosan with controllable substitution degree. 3. Dissolving the N-2-HACC prepared in step 2 in the sodium acetate buffer solution, and stirring to obtain the N-2-HACC solution; 4. adding the anionic polymer solution to the N-2-HACC solution, stirring evenly to obtain mixture. 5. Preparation of N-2-HACC-Al composite nanoparticle aluminum adjuvant. The method can improve the yield under the premise of controlling the particle size, so that the yield is greatly increased. Positively charged and stable nanoparticles show good delivery and immune enhancement. The present invention is used for preparing aluminum adjuvant for vaccine.
priorityDate 2022-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021073659-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496863
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452506388
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93091914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450770914
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6452212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456491178
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3776
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10925912
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID151263
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451906529
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16941
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID453566306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426146645
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534805
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7427
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5793
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID406903350
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID84571
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449993433
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433323524
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553385
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450984220
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23663392
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5359268
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397383
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448467028
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID441477
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID26053
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24850
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID176
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5102882
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18205
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419585621
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508054
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID517045
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425553238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415853316
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419513958
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426484532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526338

Total number of triples: 70.